Skip to content

Shoulder Injection Trial - A comparison of injection of Tenoxicam with Depo-Medrone in shoulders with subacromial impingement syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61749398
Enrollment
58
Registered
2004-09-30
Start date
2004-02-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Shoulder disorders Musculoskeletal Diseases Shoulder disorders

Interventions

Please note that, as of 27/03/2008, the end date of this trial was updated from 30/09/2004 to 17/07/2006 (date on which the last participant was recruited). Interventions added as of 27/03/2008: The

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Added as of 27/03/2008: 1. Patients over the age of 18 years 2. Clinical diagnosis of subacromial impingement syndrome 3. Symptoms lasting longer than 3 months

Exclusion criteria

Exclusion criteria: Added as of 27/03/2008: 1. Evidence of other pathology causing shoulder pain 2. Injection in the same shoulder within the previous 6 months 3. Patients taking regular systemic NSAIDs or steroids or in whom those drugs were contraindicated 4. If their present shoulder condition was the subject of any legal proceedings or insurance claims 5. Pregnant and breast-feeding mothers

Design outcomes

Primary

MeasureTime frame
Primary outcome measures updated as of 27/03/2008: Constant-Murley shoulder assessment score at baseline and 6 weeks Primary outcome measures provided at time of registration: Constant-Murley Shoulder assessment score and Disabilities of the Arm Shoulder and Hand (DASH) Questionnaire.

Secondary

MeasureTime frame
Added as of 27/03/2008: 1. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire at baseline and 2, 4 and 6 weeks 2. Oxford shoulder score at baseline and 2, 4 and 6 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026